Clinical UpdatePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Neuraxial Analgesia by Intrathecal Drug Delivery for Chronic Noncancer Pain CME
Authors: Stuart L. DuPen, MD; Anna R. DuPen, MN, ARNP
Disclosures

Release Date: December 30, 2003; Valid for credit through December 30, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.

Contents of This CME Activity
  1. Neuraxial Analgesia by Intrathecal Drug Delivery for Chronic Noncancer Pain
    Introduction
    Neuraxial Drug Delivery
    The Dilemma of Opioid Conversion
    Converting From Intravenous to Intrathecal Administration
    Intrathecal Administration of Local Anesthetics
    Other Spinally Active Agents
    Patient Selection for Intrathecal Drug Delivery
    Device Selection
    Complications
    Conclusions
    References


 
Legal Disclaimer
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2003 Medscape.

 
Medtronic
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.